{
  "meta": {
    "id": "test15",
    "title": "T-20 Pharmacology Test-1 (Pharmacokinetics) - 03-05-2023 - 2023-05-03",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which of the following is not an example of the clinical importance of enzyme induction?",
      "options": [
        {
          "label": "A",
          "text": "Phenobarbitone is used in the treatment of neonatal jaundice",
          "correct": false
        },
        {
          "label": "B",
          "text": "Phenytoin is contraindicated in acute intermittent porphyria",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tolerance occurs to anticonvulsant action of carbamazepine in few doses",
          "correct": false
        },
        {
          "label": "D",
          "text": "Omeprazole increases metabolism and thus inhibits the action of clopidogrel",
          "correct": true
        }
      ],
      "correct_answer": "D. Omeprazole increases metabolism and thus inhibits the action of clopidogrel",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Omeprazole increases the metabolism and thus inhibits the action of clopidogrel.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The concept of enzyme induction is clinically important, as it can inform treatment decisions, such as using phenobarbitone for neonatal jaundice due to its inducing effects, avoiding phenytoin in porphyria, and being aware of potential tolerance to drugs like carbamazepine . Conversely, enzyme inhibition , such as the interaction between omeprazole and clopidogrel, can significantly impact drug efficacy.</li><li>\u27a4 enzyme induction</li><li>\u27a4 inform treatment</li><li>\u27a4 using phenobarbitone</li><li>\u27a4 neonatal jaundice</li><li>\u27a4 its inducing effects, avoiding phenytoin</li><li>\u27a4 porphyria,</li><li>\u27a4 aware of potential tolerance</li><li>\u27a4 carbamazepine</li><li>\u27a4 enzyme inhibition</li><li>\u27a4 interaction between omeprazole and clopidogrel,</li><li>\u27a4 impact drug efficacy.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a83d8104",
      "audio": ""
    },
    {
      "text": "The extent to which ionization of a drug takes place is dependent upon pKa of the drug and the pH of the solution in which the drug is dissolved. Which of the following statements is NOT correct?",
      "options": [
        {
          "label": "A",
          "text": "pKa of a drug is the pH at which the drug is 50% ionized",
          "correct": false
        },
        {
          "label": "B",
          "text": "Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization",
          "correct": true
        },
        {
          "label": "C",
          "text": "Knowledge of pKa of a drug is useful in predicting its behavior in various body fluids",
          "correct": false
        },
        {
          "label": "D",
          "text": "Phenobarbitone with a pKa of 7.2 is largely unionized at acid pH and will be about 40% non-ionized in plasma",
          "correct": false
        }
      ],
      "correct_answer": "B. Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) Small changes of pH near the pKa of a weak acidic drug will not affect its degree of ionization</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The ionization of a drug in the body is critical to its pharmacokinetics and can be predicted by knowing the pKa of the drug and the pH of the environment; however, small changes in pH near the pKa can significantly affect the drug's ionization state.</li><li>\u27a4 The ionization of a drug in the body is critical to its pharmacokinetics and can be predicted by knowing the pKa of the drug and the pH of the environment; however, small changes in pH near the pKa can significantly affect the drug's ionization state.</li><li>\u27a4 ionization of a drug</li><li>\u27a4 its pharmacokinetics</li><li>\u27a4 predicted by knowing the pKa</li><li>\u27a4 drug</li><li>\u27a4 pH of the environment;</li><li>\u27a4 small changes in pH near the pKa</li><li>\u27a4 affect the drug's</li><li>\u27a4 ionization state.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e9025a7",
      "audio": ""
    },
    {
      "text": "A 70 Kg person was started on a drug with Vd =10 L and exhibits first-order elimination kinetics. The rate of drug clearance is calculated to be 6.93 L/hr. It is determined that repeating the second dose when 75% of the drug is eliminated will minimize toxicity while maintaining trough levels above the minimum inhibitory concentration. Based on these research findings, which of the following is the most appropriate dosing interval for this drug?",
      "options": [
        {
          "label": "A",
          "text": "1 hour",
          "correct": false
        },
        {
          "label": "B",
          "text": "2 hours",
          "correct": true
        },
        {
          "label": "C",
          "text": "1 day",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 hours",
          "correct": false
        }
      ],
      "correct_answer": "B. 2 hours",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) 2 hours</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 To determine the dosing interval for this drug , we need to first calculate the half-life (t1/2) of the drug. We can use the formula:</li><li>\u2022 dosing interval for this drug</li><li>\u2022 first calculate the half-life (t1/2)</li><li>\u2022 t1/2 = 0.693 x Vd / clearance</li><li>\u2022 t1/2 = 0.693 x Vd / clearance</li><li>\u2022 where Vd is the volume of distribution and clearance is the rate of drug clearance.</li><li>\u2022 Vd</li><li>\u2022 volume of distribution</li><li>\u2022 clearance</li><li>\u2022 rate of drug clearance.</li><li>\u2022 Substituting the given values, we get:</li><li>\u2022 Substituting</li><li>\u2022 values,</li><li>\u2022 t1/2 = 0.693 x 10 / 6.93 t1/2 = 1 hour</li><li>\u2022 t1/2</li><li>\u2022 1 hour</li><li>\u2022 The time to eliminate 75% of the drug would be 2 half-lives (in 1 half-life 50 percent is eliminated and in 2 half-lives 75 percent will be eliminated ) . Therefore, the time to eliminate 75% of the drug would be:</li><li>\u2022 time to eliminate 75% of the drug</li><li>\u2022 2 half-lives</li><li>\u2022 1 half-life 50 percent</li><li>\u2022 eliminated</li><li>\u2022 2 half-lives 75 percent</li><li>\u2022 eliminated</li><li>\u2022 time to eliminate 75% of the drug</li><li>\u2022 t = 2 x t1/2 = 2 x 1 = 2 hours</li><li>\u2022 t = 2 x t1/2</li><li>\u2022 2 hours</li><li>\u2022 So, the appropriate dosing interval would be around 2 hours to ensure that 75% of the previous dose is eliminated before the next dose is given.</li><li>\u2022 dosing interval</li><li>\u2022 around 2 hours</li><li>\u2022 75% of the previous dose</li><li>\u2022 eliminated before</li><li>\u2022 next</li><li>\u2022 dose is given.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For a drug with first-order elimination kinetics , a dosing interval should be set based on its half-life to minimize toxicity and maintain effective drug concentrations.</li><li>\u27a4 first-order elimination kinetics</li><li>\u27a4 dosing interval</li><li>\u27a4 its half-life</li><li>\u27a4 minimize toxicity</li><li>\u27a4 maintain effective drug concentrations.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "43934c1a",
      "audio": ""
    },
    {
      "text": "Which of the following drugs should be given in sustained release oral dosage form?",
      "options": [
        {
          "label": "A",
          "text": "An anti-arrhythmic drug with a plasma half-life of 10 seconds used for acute treatment of PSVT.",
          "correct": false
        },
        {
          "label": "B",
          "text": "An anti-inflammatory drug with a plasma half-life of 24 hr",
          "correct": false
        },
        {
          "label": "C",
          "text": "A hypnotic drug with a plasma half-life of 2 hours",
          "correct": false
        },
        {
          "label": "D",
          "text": "An antihypertensive with a plasma half-life of 3 hours",
          "correct": true
        }
      ],
      "correct_answer": "D. An antihypertensive with a plasma half-life of 3 hours",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) An antihypertensive with a plasma half-life of 3 hours</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 Sustained release oral dosage forms are most appropriate for drugs that have a short plasma half-life and are used for chronic conditions, such as an antihypertensive with a 3-hour half-life, to maintain consistent therapeutic levels and improve patient compliance with less frequent dosing.</li><li>\u27a4 Sustained release</li><li>\u27a4 forms</li><li>\u27a4 short plasma half-life</li><li>\u27a4 used for chronic</li><li>\u27a4 antihypertensive with a 3-hour half-life,</li><li>\u27a4 consistent therapeutic levels</li><li>\u27a4 improve patient compliance with less frequent dosing.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c98e8e2b",
      "audio": ""
    },
    {
      "text": "A new drug Z is being tested in animals for Anti-diabetic activity. When drug Z was given in a dose of 10 mg, 50 mice got the expected effect among the 100 who received the drug. However, at 100 mg dose, half of the animals died. Which of the following statements about drug Z is INCORRECT?",
      "options": [
        {
          "label": "A",
          "text": "The final dose of drug Z in humans should be between 10 mg and 100 mg",
          "correct": true
        },
        {
          "label": "B",
          "text": "ED50 of drug Z is 10 mg",
          "correct": false
        },
        {
          "label": "C",
          "text": "LD50 of drug Z is 100 mg",
          "correct": false
        },
        {
          "label": "D",
          "text": "Therapeutic index of drug Z is around 10",
          "correct": false
        }
      ],
      "correct_answer": "A. The final dose of drug Z in humans should be between 10 mg and 100 mg",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) The final dose of drug Z in humans should be between 10 mg and 100 mg.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 The therapeutic index (TI) of drug Z is 10 , determined by the ratio of the LD50 (dose lethal to 50% of subjects) to the ED50 (dose effective in 50% of subjects) , but the appropriate dose for humans cannot be extrapolated directly from animal data without further clinical investigation.</li><li>\u27a4 therapeutic index (TI)</li><li>\u27a4 drug Z</li><li>\u27a4 10</li><li>\u27a4 ratio of the LD50 (dose lethal to 50% of subjects) to the ED50</li><li>\u27a4 effective in 50% of subjects)</li><li>\u27a4 dose for humans</li><li>\u27a4 cannot</li><li>\u27a4 extrapolated</li><li>\u27a4 from animal data without</li><li>\u27a4 clinical investigation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9ef20367",
      "audio": ""
    },
    {
      "text": "Experiments show that 50% of an oral 100-mg dose of Drug A is absorbed in a 60-kg test subject. However, the fractional bioavailability was only 0.2. Assuming a liver blood flow of 1500 mL/min, which of the following is the hepatic clearance of Drug A in this situation?",
      "options": [
        {
          "label": "A",
          "text": "300 mL/min",
          "correct": false
        },
        {
          "label": "B",
          "text": "450 mL/min",
          "correct": false
        },
        {
          "label": "C",
          "text": "600 mL/min",
          "correct": false
        },
        {
          "label": "D",
          "text": "900 mL/min",
          "correct": true
        }
      ],
      "correct_answer": "D. 900 mL/min",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 900 mL/min</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Absorption and Bioavailability : 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg . Amount Extracted by the Liver : 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50\u2009mg \u2212 20 \u2009mg = 30\u2009mg Hepatic Extraction Ratio (ER) : The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30\u2009mg / 50\u2009mg = 0.6 Hepatic Clearance (Cl\u2095) : Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) \u00d7 Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500\u2009mL/min \u00d7 0.6 = 900\u2009mL/min</li><li>\u2022 Absorption and Bioavailability : 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .</li><li>\u2022 Absorption and Bioavailability :</li><li>\u2022 Absorption and Bioavailability</li><li>\u2022 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver. The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .</li><li>\u2022 50% of the 100 mg dose of Drug A is absorbed, so 50 mg reaches the liver.</li><li>\u2022 50% of the 100 mg dose</li><li>\u2022 50 mg</li><li>\u2022 The fractional bioavailability (F) is 0.2 , meaning 20% of the absorbed drug reaches the systemic circulation , or 20 mg .</li><li>\u2022 fractional bioavailability (F)</li><li>\u2022 0.2</li><li>\u2022 20%</li><li>\u2022 systemic circulation</li><li>\u2022 20 mg</li><li>\u2022 Amount Extracted by the Liver : 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50\u2009mg \u2212 20 \u2009mg = 30\u2009mg</li><li>\u2022 Amount Extracted by the Liver :</li><li>\u2022 Amount Extracted by the Liver</li><li>\u2022 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation. Therefore, the amount extracted by the liver is: 50\u2009mg \u2212 20 \u2009mg = 30\u2009mg</li><li>\u2022 50 mg of the absorbed drug reaches the liver, and 20 mg exits into the systemic circulation.</li><li>\u2022 50 mg</li><li>\u2022 20 mg</li><li>\u2022 Therefore, the amount extracted by the liver is: 50\u2009mg \u2212 20 \u2009mg = 30\u2009mg</li><li>\u2022 amount extracted by the liver</li><li>\u2022 Hepatic Extraction Ratio (ER) : The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30\u2009mg / 50\u2009mg = 0.6</li><li>\u2022 Hepatic Extraction Ratio (ER) :</li><li>\u2022 Hepatic Extraction Ratio (ER)</li><li>\u2022 The hepatic extraction ratio is the fraction of the drug extracted by the liver : ER = Amount extracted by the liver/Amount reaching the liver = 30\u2009mg / 50\u2009mg = 0.6</li><li>\u2022 The hepatic extraction ratio is the fraction of the drug extracted by the liver :</li><li>\u2022 hepatic extraction ratio</li><li>\u2022 fraction of the drug extracted by the liver</li><li>\u2022 ER = Amount extracted by the liver/Amount reaching the liver = 30\u2009mg / 50\u2009mg = 0.6</li><li>\u2022 Hepatic Clearance (Cl\u2095) : Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) \u00d7 Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500\u2009mL/min \u00d7 0.6 = 900\u2009mL/min</li><li>\u2022 Hepatic Clearance (Cl\u2095) :</li><li>\u2022 Hepatic Clearance (Cl\u2095)</li><li>\u2022 Hepatic clearance is given by the formula: CL = Liver Blood Flow (Q) \u00d7 Extraction Ratio Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 : CL = 1500\u2009mL/min \u00d7 0.6 = 900\u2009mL/min</li><li>\u2022 Hepatic clearance is given by the formula:</li><li>\u2022 CL = Liver Blood Flow (Q) \u00d7 Extraction Ratio</li><li>\u2022 Given that the liver blood flow (Q) is 1500 mL/min (or 1.5 L/min) and the extraction ratio (ER) is 0.6 :</li><li>\u2022 liver blood flow (Q)</li><li>\u2022 1500 mL/min</li><li>\u2022 extraction ratio (ER)</li><li>\u2022 0.6</li><li>\u2022 CL = 1500\u2009mL/min \u00d7 0.6 = 900\u2009mL/min</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 To calculate the hepatic clearance of a drug , apply the formula hepatic clearance = hepatic extraction ratio \u00d7 hepatic blood flow, using the fraction of the drug dose absorbed and the fractional bioavailability to determine the extraction ratio .</li><li>\u27a4 hepatic clearance of a drug</li><li>\u27a4 hepatic clearance = hepatic extraction ratio \u00d7 hepatic blood flow,</li><li>\u27a4 fraction of the drug</li><li>\u27a4 absorbed and the fractional bioavailability</li><li>\u27a4 extraction ratio</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "09f60603",
      "audio": ""
    },
    {
      "text": "Which of the following figures correctly represent the relationship between clearance and plasma concentration for a drug following first order kinetics?",
      "options": [
        {
          "label": "A",
          "text": "a",
          "correct": true
        },
        {
          "label": "B",
          "text": "b",
          "correct": false
        },
        {
          "label": "C",
          "text": "c",
          "correct": false
        },
        {
          "label": "D",
          "text": "d",
          "correct": false
        }
      ],
      "correct_answer": "A. a",
      "question_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/screenshot-2023-05-03-111308.jpg"
      ],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Figure a represents a scenario where clearance is independent of plasma concentration . This is consistent with first-order kinetics, where a constant fraction of the drug is eliminated per unit time. Figure b suggests that clearance increases linearly with increasing plasma concentration, which would imply dose-dependent kinetics , not first-order kinetics. Figure c and d both show clearance changing with plasma concentration , which suggests non-linear kinetics.</li><li>\u2022 Figure a represents a scenario where clearance is independent of plasma concentration . This is consistent with first-order kinetics, where a constant fraction of the drug is eliminated per unit time.</li><li>\u2022 Figure a</li><li>\u2022 clearance is independent of plasma concentration</li><li>\u2022 first-order kinetics,</li><li>\u2022 constant fraction of the drug</li><li>\u2022 eliminated</li><li>\u2022 unit time.</li><li>\u2022 Figure b suggests that clearance increases linearly with increasing plasma concentration, which would imply dose-dependent kinetics , not first-order kinetics.</li><li>\u2022 Figure b</li><li>\u2022 clearance increases linearly</li><li>\u2022 increasing plasma concentration,</li><li>\u2022 dose-dependent kinetics</li><li>\u2022 Figure c and d both show clearance changing with plasma concentration , which suggests non-linear kinetics.</li><li>\u2022 Figure c and d</li><li>\u2022 show clearance</li><li>\u2022 with plasma concentration</li><li>\u2022 non-linear kinetics.</li><li>\u2022 Therefore, the figure that correctly represents the relationship between clearance and plasma concentration for a drug following first-order kinetics is: Figure a .</li><li>\u2022 the figure</li><li>\u2022 correctly represents</li><li>\u2022 relationship between clearance and plasma concentration</li><li>\u2022 first-order kinetics</li><li>\u2022 Figure a</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 In first-order kinetics, the clearance of a drug remains constant regardless of plasma concentration , which is depicted as a horizontal line parallel to the plasma concentration axis in a graph of clearance versus plasma concentration.</li><li>\u27a4 first-order kinetics,</li><li>\u27a4 clearance of a drug</li><li>\u27a4 constant</li><li>\u27a4 plasma concentration</li><li>\u27a4 horizontal</li><li>\u27a4 line parallel to the plasma concentration</li><li>\u27a4 axis</li><li>\u27a4 clearance versus plasma concentration.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e6882c55",
      "audio": ""
    },
    {
      "text": "Phenytoin is a drug that follows zero order kinetics at high doses and first order kinetics at low doses. Suppose 400 mg phenytoin is present in the body and its rate of elimination at this dose is 200 mg/hr., how much will remain in plasma after 2 hours?",
      "options": [
        {
          "label": "A",
          "text": "100 mg",
          "correct": false
        },
        {
          "label": "B",
          "text": "50 mg",
          "correct": false
        },
        {
          "label": "C",
          "text": "Zero",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cannot be predicted from this information",
          "correct": true
        }
      ],
      "correct_answer": "D. Cannot be predicted from this information",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) Cannot be predicted from this information.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 For drugs like phenytoin , which exhibit zero-order kinetics at higher doses and first-order kinetics at lower doses , the specific plasma concentration at which this shift occurs must be known to accurately predict plasma levels after a given period.</li><li>\u27a4 phenytoin</li><li>\u27a4 exhibit zero-order kinetics at higher doses</li><li>\u27a4 first-order kinetics at lower doses</li><li>\u27a4 plasma concentration</li><li>\u27a4 shift</li><li>\u27a4 accurately predict plasma levels</li><li>\u27a4 given period.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3af39273",
      "audio": ""
    },
    {
      "text": "Which of the following drugs would most likely need a loading dose to help reach therapeutic levels?",
      "options": [
        {
          "label": "A",
          "text": "Acetaminophen, t (1/2) = 2 h",
          "correct": false
        },
        {
          "label": "B",
          "text": "Aspirin, t (1/2) = 15 min",
          "correct": false
        },
        {
          "label": "C",
          "text": "Digitoxin, t (1/2) = 161 h",
          "correct": true
        },
        {
          "label": "D",
          "text": "Adenosine, t (1/2) = 10 s",
          "correct": false
        }
      ],
      "correct_answer": "C. Digitoxin, t (1/2) = 161 h",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Digitoxin, t1/2= 161 hrs</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Aspirin (t\u00bd = 15 minutes) : Aspirin has a very short half-life, meaning it rapidly reaches steady-state levels with regular dosing. A loading dose is typically unnecessary because the drug accumulates quickly.</li><li>\u2022 Aspirin (t\u00bd = 15 minutes)</li><li>\u2022 Acetaminophen (t\u00bd = 2 hours) : While acetaminophen has a longer half-life compared to aspirin, it still reaches therapeutic levels relatively quickly with regular dosing, making a loading dose unnecessary.</li><li>\u2022 Acetaminophen (t\u00bd = 2 hours)</li><li>\u2022 Adenosine (t\u00bd = 10 seconds) : Adenosine has an extremely short half-life and is used for acute, rapid-onset effects, such as in the treatment of supraventricular tachycardia. Because of its immediate action and short duration, no loading dose is needed.</li><li>\u2022 Adenosine (t\u00bd = 10 seconds)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Drugs with a long half-life (such as digitoxin) require a loading dose to achieve therapeutic concentrations quickly. This is particularly important in clinical scenarios where immediate drug effects are needed. For drugs with short half-lives, a loading dose is typically unnecessary because steady-state levels are rapidly reached with regular dosing.</li><li>\u27a4 long half-life</li><li>\u27a4 loading dose</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1476e507",
      "audio": ""
    },
    {
      "text": "Constant intravenous infusion (at a rate of 200 mg/hour) of a drug with half-life of 1 hour is started and plasma concentration is measured at different intervals. If steady state plasma concentration is 400 \u00b5g/dl, what was the likely plasma concentration at 2 hours\u2019 time after starting the infusion?",
      "options": [
        {
          "label": "A",
          "text": "100 \u00b5g/dl",
          "correct": false
        },
        {
          "label": "B",
          "text": "150 \u00b5g/dl",
          "correct": false
        },
        {
          "label": "C",
          "text": "200 \u00b5g/dl",
          "correct": false
        },
        {
          "label": "D",
          "text": "300 \u00b5g/dl",
          "correct": true
        }
      ],
      "correct_answer": "D. 300 \u00b5g/dl",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) 300 \u00b5g/dl</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 During constant intravenous infusion , plasma concentration of a drug with a half-life of 1 hour at 2 hours is likely to be 75% of the steady-state concentration due to exponential accumulation.</li><li>\u27a4 constant intravenous infusion</li><li>\u27a4 plasma concentration</li><li>\u27a4 half-life of 1 hour at 2 hours</li><li>\u27a4 75%</li><li>\u27a4 steady-state concentration</li><li>\u27a4 exponential accumulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "770967d4",
      "audio": ""
    },
    {
      "text": "Time for peak plasma concentration (Tmax) indicates?",
      "options": [
        {
          "label": "A",
          "text": "The rate of elimination",
          "correct": false
        },
        {
          "label": "B",
          "text": "The rate of absorption",
          "correct": true
        },
        {
          "label": "C",
          "text": "The duration of effect",
          "correct": false
        },
        {
          "label": "D",
          "text": "The extent of absorption",
          "correct": false
        }
      ],
      "correct_answer": "B. The rate of absorption",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B) The rate of absorption</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. The rate of elimination: Incorrect. The rate of elimination is more closely related to the drug's half-life (t1/2), which is the time required for the plasma concentration of the drug to reduce to half its initial value . Tmax does not provide direct information about the rate at which the drug is eliminated from the body.</li><li>\u2022 Option A. The rate of elimination:</li><li>\u2022 Incorrect.</li><li>\u2022 rate of elimination</li><li>\u2022 closely related to the drug's half-life (t1/2),</li><li>\u2022 time required for the plasma concentration</li><li>\u2022 reduce to half its initial value</li><li>\u2022 Tmax does not</li><li>\u2022 information</li><li>\u2022 rate at</li><li>\u2022 drug is eliminated</li><li>\u2022 Option C. The duration of effect: Incorrect . The duration of effect of a drug is influenced by its half-life and the duration of interaction with its target receptors , not just the time to reach peak concentration. Tmax alone does not provide complete information about how long a drug's effects will last.</li><li>\u2022 Option C. The duration of effect:</li><li>\u2022 Incorrect</li><li>\u2022 duration of effect of a drug</li><li>\u2022 its half-life and the duration of</li><li>\u2022 interaction</li><li>\u2022 target receptors</li><li>\u2022 not</li><li>\u2022 time to reach peak concentration.</li><li>\u2022 Tmax</li><li>\u2022 does not</li><li>\u2022 complete</li><li>\u2022 information</li><li>\u2022 long a drug's effects</li><li>\u2022 last.</li><li>\u2022 Option D. The extent of absorption: Incorrect. The extent of absorption is more accurately indicated by the area under the curve (AUC) or the total plasma concentration of the drug over time . Tmax tells us when the peak concentration occurs but does not indicate the total amount of drug absorbed.</li><li>\u2022 Option D. The extent of absorption:</li><li>\u2022 Incorrect.</li><li>\u2022 extent of absorption</li><li>\u2022 more</li><li>\u2022 indicated</li><li>\u2022 area under the curve</li><li>\u2022 total plasma concentration</li><li>\u2022 drug over time</li><li>\u2022 Tmax</li><li>\u2022 peak concentration</li><li>\u2022 does not</li><li>\u2022 indicate</li><li>\u2022 total amount of drug absorbed.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Tmax is a pharmacokinetic parameter that indicates the time at which a drug reaches its maximum concentration in plasma , reflecting the rate of absorption from the site of administration into the systemic circulation.</li><li>\u2022 Tmax</li><li>\u2022 pharmacokinetic</li><li>\u2022 indicates the time</li><li>\u2022 drug</li><li>\u2022 its maximum concentration in plasma</li><li>\u2022 reflecting the rate of absorption</li><li>\u2022 site of administration</li><li>\u2022 systemic circulation.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "358d8f02",
      "audio": ""
    },
    {
      "text": "All the following factors tend to increase the volume of distribution of a drug EXCEPT:",
      "options": [
        {
          "label": "A",
          "text": "High plasma protein binding",
          "correct": true
        },
        {
          "label": "B",
          "text": "Low ionization at physiological pH values",
          "correct": false
        },
        {
          "label": "C",
          "text": "High lipid solubility",
          "correct": false
        },
        {
          "label": "D",
          "text": "High tissue binding",
          "correct": false
        }
      ],
      "correct_answer": "A. High plasma protein binding",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A) High plasma protein binding.</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 While high lipid solubility, low ionization , and high tissue binding increase a drug's volume of distribution , high plasma protein binding generally decreases it.</li><li>\u27a4 high lipid solubility,</li><li>\u27a4 low ionization</li><li>\u27a4 high tissue binding increase</li><li>\u27a4 drug's volume of distribution</li><li>\u27a4 high plasma protein</li><li>\u27a4 binding</li><li>\u27a4 decreases it.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3b2fca36",
      "audio": ""
    },
    {
      "text": "All of the following statements regarding steady state plasma concentration of a drug are true EXCEPT:",
      "options": [
        {
          "label": "A",
          "text": "At steady state, rate of administration of drug is equal to its rate of elimination",
          "correct": false
        },
        {
          "label": "B",
          "text": "Steady state plasma concentration achieved depends upon half-life",
          "correct": true
        },
        {
          "label": "C",
          "text": "Drugs with longer half-life can be given as loading dose to achieve steady state more quickly",
          "correct": false
        },
        {
          "label": "D",
          "text": "Average steady state plasma concentration achieved is same irrespective of once daily or twice daily administration if total daily dose is same",
          "correct": false
        }
      ],
      "correct_answer": "B. Steady state plasma concentration achieved depends upon half-life",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Steady state plasma concentration achieved depends upon half-life.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fefd45d2",
      "audio": ""
    },
    {
      "text": "A drug x is secreted through renal tubules, tubular secretion of this drug can be confirmed if renal clearance of drug x is:",
      "options": [
        {
          "label": "A",
          "text": "Equal to the GFR",
          "correct": false
        },
        {
          "label": "B",
          "text": "More than the GFR",
          "correct": true
        },
        {
          "label": "C",
          "text": "Less than the GFR",
          "correct": false
        },
        {
          "label": "D",
          "text": "More than volume of distribution",
          "correct": false
        }
      ],
      "correct_answer": "B. More than the GFR",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. More than the GFR</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a9a85cc1",
      "audio": ""
    },
    {
      "text": "A new drug is found to be highly lipid soluble. It is metabolized at a slower rate of 10% per hour. On intravenous injection it produces general anaesthesia that lasts only for 15 min. This short duration of anaesthesia is due to?",
      "options": [
        {
          "label": "A",
          "text": "Metabolism of the drug in liver",
          "correct": false
        },
        {
          "label": "B",
          "text": "High plasma protein binding of the drug",
          "correct": false
        },
        {
          "label": "C",
          "text": "Excretion of drug by kidney",
          "correct": false
        },
        {
          "label": "D",
          "text": "Redistribution",
          "correct": true
        }
      ],
      "correct_answer": "D. Redistribution",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Redistribution</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "131e2f15",
      "audio": ""
    },
    {
      "text": "Oral loading dose of a drug depends on the following factors except:",
      "options": [
        {
          "label": "A",
          "text": "Drug concentration to be achieved",
          "correct": false
        },
        {
          "label": "B",
          "text": "Volume of distribution",
          "correct": false
        },
        {
          "label": "C",
          "text": "Bioavailability of drug",
          "correct": false
        },
        {
          "label": "D",
          "text": "Clearance of the drug",
          "correct": true
        }
      ],
      "correct_answer": "D. Clearance of the drug",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Clearance of the drug</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "cf9cad2a",
      "audio": ""
    },
    {
      "text": "A three-year-old child is brought to the emergency department having just ingested a large overdose of an antihistaminic drug. This drug is a weak base capable of entering most tissues including the brain. On physical examination the heart rate is 100/minute, blood pressure is 110/60 mm Hg and the respiratory rate is 20/ minute. In this case of poisoning?",
      "options": [
        {
          "label": "A",
          "text": "Urinary excretion would be accelerated by administration of NaHCO3, an alkalinizing agent",
          "correct": false
        },
        {
          "label": "B",
          "text": "Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent",
          "correct": true
        },
        {
          "label": "C",
          "text": "More of the drug would be ionized at blood pH than at stomach pH",
          "correct": false
        },
        {
          "label": "D",
          "text": "Absorption of the drug would be faster from the stomach than from the small intestine.",
          "correct": false
        }
      ],
      "correct_answer": "B. Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. \u00a0Urinary excretion would be accelerated by administration of NH4Cl, an acidifying agent.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "56f0763e",
      "audio": ""
    },
    {
      "text": "About first order kinetics true statement is?",
      "options": [
        {
          "label": "A",
          "text": "Clearance remains constant",
          "correct": true
        },
        {
          "label": "B",
          "text": "Fixed amount of the drug is eliminated per unit time",
          "correct": false
        },
        {
          "label": "C",
          "text": "Half-life increases with dose",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rate of elimination is constant",
          "correct": false
        }
      ],
      "correct_answer": "A. Clearance remains constant",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A.</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c57037cd",
      "audio": ""
    },
    {
      "text": "Drug X is normally administered to patients at a rate of 50 mg/hour. Elimination of the drug X from body takes place as: - Hepatic Metabolism 10% - Biliary Secretion 10% - Renal Excretion 80% This drug has to be administered to a 65 years old patient Uttam Singh, with a GFR of 60 ml/min. (assuming normal GFR is 120 ml/min). Liver and biliary functions are normal in this patient. What should be the dose rate of drug X in this patient?",
      "options": [
        {
          "label": "A",
          "text": "50 mg/hour",
          "correct": false
        },
        {
          "label": "B",
          "text": "25 mg/hour",
          "correct": false
        },
        {
          "label": "C",
          "text": "30 mg/hour",
          "correct": true
        },
        {
          "label": "D",
          "text": "100 mg/hour",
          "correct": false
        }
      ],
      "correct_answer": "C. 30 mg/hour",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 30 mg/hour</strong></p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "25dfe6a2",
      "audio": ""
    },
    {
      "text": "A patient, Rajesh with a history of wheezing, coughing and shortness of breath is being evaluated in the asthma clinic. Several drug treatments with different routes are under consideration. Which of the following statements about routes of administration is most correct?",
      "options": [
        {
          "label": "A",
          "text": "Administration of a bronchodilator drug by inhaled aerosol is usually associated with more adverse effects than administration of this drug by mouth",
          "correct": false
        },
        {
          "label": "B",
          "text": "Bioavailability of most drugs is greater with rectal administration than with sublingual administration",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administration of a drug by transdermal patch is often faster but is associated with more first pass metabolism than oral administration",
          "correct": false
        },
        {
          "label": "D",
          "text": "The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation",
          "correct": true
        }
      ],
      "correct_answer": "D. The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D) The first pass effect is the result of elimination of a drug after administration and before it enters systemic circulation</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. is incorrect because inhaled aerosol administration of bronchodilator drugs is associated with fewer adverse effects than oral administration , as it allows for targeted delivery of the drug to the site of action in the lungs, with minimal systemic absorption.</li><li>\u2022 Option A.</li><li>\u2022 incorrect</li><li>\u2022 inhaled aerosol administration</li><li>\u2022 fewer adverse effects</li><li>\u2022 oral administration</li><li>\u2022 allows for targeted delivery of the drug</li><li>\u2022 site of action in the lungs,</li><li>\u2022 minimal systemic</li><li>\u2022 absorption.</li><li>\u2022 Option B. is incorrect because sublingual administration generally results in greater bioavailability than rectal administration, as the sublingual route allows for rapid absorption of the drug into the bloodstream through the rich network of blood vessels under the tongue , bypassing the first-pass metabolism in the liver.</li><li>\u2022 Option B.</li><li>\u2022 incorrect</li><li>\u2022 sublingual administration</li><li>\u2022 greater bioavailability</li><li>\u2022 rectal administration,</li><li>\u2022 sublingual route</li><li>\u2022 rapid absorption of the drug</li><li>\u2022 bloodstream</li><li>\u2022 rich network of blood vessels</li><li>\u2022 tongue</li><li>\u2022 bypassing</li><li>\u2022 first-pass metabolism in the liver.</li><li>\u2022 Option C. is incorrect because transdermal administration of a drug is associated with slower onset of action than oral administration, as the drug must penetrate the skin barrier to enter systemic circulation.</li><li>\u2022 Option C.</li><li>\u2022 incorrect</li><li>\u2022 transdermal administration</li><li>\u2022 slower onset of action</li><li>\u2022 oral</li><li>\u2022 administration,</li><li>\u2022 drug</li><li>\u2022 penetrate the skin</li><li>\u2022 enter systemic circulation.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 First pass effect refers to the metabolism of a drug within the liver that significantly reduces the bioavailability of the drug before it reaches systemic circulation , as opposed to comparing routes of administration and their impact on drug delivery and metabolism.</li><li>\u2022 First pass effect</li><li>\u2022 metabolism of a drug</li><li>\u2022 liver</li><li>\u2022 reduces</li><li>\u2022 bioavailability of the drug before</li><li>\u2022 systemic circulation</li><li>\u2022 comparing routes of administration</li><li>\u2022 their impact</li><li>\u2022 drug delivery</li><li>\u2022 metabolism.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5c39b851",
      "audio": ""
    }
  ]
}